Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2008
10/21/2008US7438203 Dermal penetration enhancers and drug delivery systems involving same
10/21/2008CA2412708C Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
10/21/2008CA2368823C Use of dopamine d3 receptor ligands for producing medicaments for treating kidney disorders
10/21/2008CA2293346C Device and method for treatment of dysmenorrhea
10/21/2008CA2232294C Bioactive factors of aloe vera plants
10/21/2008CA2230452C Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
10/21/2008CA2220226C Improved methods for transfecting t cells
10/21/2008CA2169071C Methods for modulating the human sexual response
10/21/2008CA2042064C C-erbb-2 external domain:gp75
10/20/2008CA2629419A1 Dietary supplement for the compensation of nutritional deficiency
10/16/2008WO2008124699A1 A method of using proteasome inhibitors in combination with histone deacetylase inhibitors to treat cancer
10/16/2008WO2008124522A2 Amylin formulations
10/16/2008WO2008124483A1 Protein cage immunotherapeutics
10/16/2008WO2008124161A1 Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
10/16/2008WO2008124088A2 Compositions and methods for the treatment of heart failure
10/16/2008WO2008124085A2 Methods of using combinations of mek and jak-2 inhibitors
10/16/2008WO2008124081A2 Rapid dissolution of combination products
10/16/2008WO2008124009A2 Treating glaucoma
10/16/2008WO2008123395A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
10/16/2008WO2008122798A2 Pharmaceutical composition of an eg5 inhibitor and a microtubule interfering agent for the treatment of cancer
10/16/2008WO2008122779A1 Combination of a purine-based cdk inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders
10/16/2008WO2008057337A3 Use of dipeptidyl peptidase iv inhibitors for preventing, delaying or reducing the occurance of edema
10/16/2008WO2008026156A3 Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor
10/16/2008WO2007115289A8 Combinations comprising bcr-abl/c-kit/pdgf-r tk inhibitors for treating cancer
10/16/2008WO2007094924A3 Human telomerase reverse transcriptase peptides
10/16/2008US20080255557 High strength suture with absorbable core and suture anchor combination
10/16/2008US20080255252 Infectious Aetiology of Prostatic Disease and Methods to Identify Causative Agents
10/16/2008US20080255250 Compounds and Compositions for Delivering Active Agents
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255209 Combination of a NSAID and a PDE-4 inhibitor
10/16/2008US20080255132 Combination Therapy Comprising the Use of Et-743 and Paclitaxel for Treating Cancer
10/16/2008US20080254527 VON WILLEBRAND FACTOR (vWF) - CLEAVING PROTEASE
10/16/2008US20080254506 Claudin polypeptides
10/16/2008US20080254447 Using CpG site methylation of breast cancer tumor antigens as evaluative tools in prognosing/diagnosing cell proliferative disorders
10/16/2008US20080254142 Compositions and methods for nutrition supplementation
10/16/2008US20080254127 Inhalation particles incorporating a combination of two or more active ingredients
10/16/2008US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
10/16/2008US20080254064 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
10/16/2008US20080254040 Antagonists of receptors of enothelial growth factor, platelet-derived growth factor, fibroblast growth factor, epidermal growth factors, HER2, IGF1R, HGFR or c-Kit, which is further an antagonist of a src tyrosine kinase family member, and chemotherapeutic agent; co-treatment with radiation therapy
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254019 Therapeutic Agents and Therapeutic Methods For Treating Injured Tissue
10/16/2008US20080253999 Methods For Differentiating Stem Cells and Uses Thereof in the Treatment of Dental Conditions
10/16/2008US20080253993 Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope
10/16/2008US20080253991 Using glutamic acid decarboxylase (GAD) autoantigen, cd3 specific antibodies and lymphocyte specific antibodies to treat and prevent new onset type I diabetes in mammals
10/16/2008CA2683641A1 Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
10/16/2008CA2682872A1 Rapid dissolution of combination products
10/16/2008CA2682234A1 Compositions and methods for the treatment of heart failure
10/16/2008CA2680838A1 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient
10/15/2008EP1980271A1 Medicine for transnasal administration
10/15/2008EP1980263A1 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections
10/15/2008EP1980257A1 Compositions and uses of galectin antagonists
10/15/2008EP1980252A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
10/15/2008EP1980249A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2008EP1980243A1 Liposome preparation
10/15/2008EP1979002A2 Combination of igfr inhibitor and anti-cancer agent
10/15/2008EP1978993A2 Compositions and methods for diagnosing and treating cancer
10/15/2008EP1978984A2 Nutritional system and methods for increasing longevity
10/15/2008EP1978968A2 Cationic steroid antimicrobial compositions for treating or preventing hiv infections
10/15/2008EP1978962A2 Compositions and methods of treatment using modulators of motonueron diseases
10/15/2008EP1978955A1 New pharmaceutical compositions based on anticholinergics and andolast
10/15/2008EP1978949A2 Combination preparation for improving sperm quality
10/15/2008EP1694338B1 Use of mimetics of superoxide dismutase and of reductase glutathione in the form of anticancer drugs
10/15/2008EP1660085B1 Pyridylpyrrole derivatives active as kinase inhibitors
10/15/2008EP1476423B1 Arylsulfonamidobenzylic compounds
10/15/2008EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
10/15/2008EP1432379B1 Methods for inhibiting cognitive deterioration in adults with down's syndrome
10/15/2008EP1427409B1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
10/15/2008EP1414421B1 The treatment of lipodystrophy with inhibitors of the renin angiotensin system
10/15/2008EP1411982B1 Modulators of p-selectin glycoprotein ligand 1
10/15/2008EP1411940B1 Bridged piperidine derivatives as melanocortin receptor agonists
10/15/2008EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
10/15/2008EP1379207A4 Composition for freshening nostrils and sinus cavities
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1351742B1 Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
10/15/2008EP1296995B1 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
10/15/2008EP1272517B1 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/15/2008EP1242456B1 Scfv antibodies against disease associated molecules
10/15/2008EP1019057B1 A method of preventing or treating estrogen-dependent diseases and disorders
10/15/2008EP0841946B2 Methods for treatment of allergic asthma
10/15/2008CN101287496A Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration
10/15/2008CN101287495A Direct compression formulation of DPP-IV inhibitors and glitazones, and process
10/15/2008CN101287494A Methods for treating dermatitis using mutant human IL-4 compositions
10/15/2008CN101287461A Use of 5-amido-1h-pyrrole-2-nitrile derivative as progesterone receptor modulators
10/15/2008CN101285061A Fungal cell wall synthesis gene
10/15/2008CN101284865A New compound and its medicine use
10/15/2008CN101283995A Different pharmaceutical uses alpha2delta ligands
10/15/2008CN101283978A Anticancer sustained-release gel injection containing platinum compound
10/15/2008CN101283977A Sustained-release gel injection loaded with platinum compound and alkyl agent
10/15/2008CN101283976A Anticancer sustained-release gel injection containing taxone medicine
10/15/2008CN101283975A Anticancer sustained-release gel injection containing neonatal blood vessel inhibitor
10/15/2008CN101283974A Anticancer sustained-release gel injection and preparation method thereof
10/15/2008CN101283933A Artificial crystalline lens of blocking eaves type limitation after cataract
10/15/2008CN100425284C Methods for glucagon suppression
10/15/2008CN100425241C Glaucoma-treating agent consisting of RHo kinase inhibitor and prostaglandin
10/14/2008US7435870 administering nucleic acids to fish and detecting changes in messenger RNA in the cells, tissues or organs using a cDNA microarray, in response to the nucleic acids; screening drugs for neovscularization, apoptosis or toxic activity
10/14/2008US7435806 Detection of preferential transcription factor; obtain library, screen with probe, detect hybridization, recover clone, monitor transcriptional activity of protein codes in cloned nucleotide sequences
10/14/2008US7435756 Preparation and diabetic use of gibberellins
10/14/2008US7435745 Methods and compositions for inhibition of angiogenesis